Correlation Between Bank of America and Ono Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Bank of America and Ono Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Ono Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bank of America and Ono Pharmaceutical Co, you can compare the effects of market volatilities on Bank of America and Ono Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Ono Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Ono Pharmaceutical.

Diversification Opportunities for Bank of America and Ono Pharmaceutical

0.24

Correlation Coefficient

Bank of America  Ono Pharmaceutical

Modest diversification

The 3 months correlation between Bank and Ono is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Ono Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ono Pharmaceutical and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Ono Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ono Pharmaceutical has no effect on the direction of Bank of America i.e., Bank of America and Ono Pharmaceutical go up and down completely randomly.

Pair Corralation between Bank of America and Ono Pharmaceutical

Considering the 90-day investment horizon Bank of America is expected to under-perform the Ono Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Bank of America is 3.41 times less risky than Ono Pharmaceutical. The stock trades about -0.02 of its potential returns per unit of risk. The Ono Pharmaceutical Co is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  1,084  in Ono Pharmaceutical Co on December 26, 2024 and sell it today you would earn a total of  35.00  from holding Ono Pharmaceutical Co or generate 3.23% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	41.67%
Values	Daily Returns

Bank of America  vs.  Ono Pharmaceutical Co

Bank of America

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bank of America has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Bank of America is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Ono Pharmaceutical

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Ono Pharmaceutical Co are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Ono Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bank of America and Ono Pharmaceutical

The main advantage of trading using opposite Bank of America and Ono Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Ono Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ono Pharmaceutical will offset losses from the drop in Ono Pharmaceutical's long position.

The idea behind Bank of America and Ono Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.